Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia - Wikidata - awgldk - TriplyDB

Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia

Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia

http://www.wikidata.org/entity/Q37020101

about

Bone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategies High-mobility group box 1: an amplifier of stem and progenitor cell activity after stroke Cell based therapies for ischemic stroke: from basic science to bedside Stem cells in human neurodegenerative disorders--time for clinical translation?Improving the efficacy of therapeutic angiogenesis by UTMD-mediated Ang-1 gene delivery to the infarcted myocardium.Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury.BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury.Neural repair and neuroprotection with stem cells in ischemic stroke.Development of a middle cerebral artery occlusion model in the nonhuman primate and a safety study of i.v. infusion of human mesenchymal stem cells.Transplanted bone marrow stromal cells protect neurovascular units and ameliorate brain damage in stroke-prone spontaneously hypertensive rats.Genetic engineering of mesenchymal stem cells and its application in human disease therapy.Stem cell-based treatments against stroke: observations from human proof-of-concept studies and considerations regarding clinical applicability.Comparative study among three different methods of bone marrow mesenchymal stem cell transplantation following cerebral infarction in rats.Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.COMP-Ang1 Potentiates EPC Treatment of Ischemic Brain Injury by Enhancing Angiogenesis Through Activating AKT-mTOR Pathway and Promoting Vascular Migration Through Activating Tie2-FAK Pathway Adult vascular wall resident multipotent vascular stem cells, matrix metalloproteinases, and arterial aneurysms.Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?Immune effects of mesenchymal stromal cells in experimental stroke.Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair.Fantasies about stem cell therapy in chronic ischemic stroke patients Systemic delivery of umbilical cord blood cells for stroke therapy: a review.Magnetic resonance imaging and fluorescence labeling of clinical-grade mesenchymal stem cells without impacting their phenotype: study in a rat model of stroke Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats.Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities.Assessment of immunosuppressive activity of human mesenchymal stem cells using murine antigen specific CD4 and CD8 T cells in vitro.Increasing injection frequency enhances the survival of injected bone marrow derived mesenchymal stem cells in a critical limb ischemia animal model.Engineered adenosine-releasing cells for epilepsy therapy: human mesenchymal stem cells and human embryonic stem cells The rodent endovascular puncture model of subarachnoid hemorrhage: mechanisms of brain damage and therapeutic strategies.Mesenchymal stem cells transplantation suppresses inflammatory responses in global cerebral ischemia: contribution of TNF-α-induced protein 6.Gene transfer mediated by stem cell grafts to treat CNS injury.Neural stem cells and stroke.The endogenous regenerative capacity of the damaged newborn brain: boosting neurogenesis with mesenchymal stem cell treatment.Update on therapeutic mechanism for bone marrow stromal cells in ischemic stroke.Intravascular stem cell transplantation for stroke.Bone marrow stromal cells as a therapeutic treatment for ischemic stroke.Opportunities and challenges: stem cell-based therapy for the treatment of ischemic stroke.Engineering Stem Cells for Biomedical Applications.Human Dental Pulp Stem Cells Are More Effective Than Human Bone Marrow-Derived Mesenchymal Stem Cells in Cerebral Ischemic Injury.Current developments in cell- and biomaterial-based approaches for stroke repair.

P2860

Q26740083-1F58FD5F-A1EF-4E07-B1B4-C443E2A1E049 Q27008225-49E0E473-BF85-4CFE-89A5-27CBC9B65E67 Q27025754-FDA47DE3-988C-4C30-AADF-DA0E18C6E0D3 Q27687068-5987395B-E21F-4DD1-BB0B-9469C2BAD278 Q30397684-3ADF17C9-E2AF-40F6-9003-2F3EE153C836 Q30533831-8C6CC27F-52F5-4E84-BC77-C5516ED680A1 Q33672421-AB6A89E3-A83A-4FA1-9216-31BF8C1C0085 Q33772112-5E370D80-FEB3-4853-8752-3683E8E88B48 Q34062490-C8EB507D-CE92-41B3-A9BE-FB34C7F3E934 Q34125531-541DD0FA-E9E7-4C77-B3AF-4644B42F58A6 Q34298871-A861CA8D-00EA-432F-841D-999E1B41AC6D Q34419548-510A926E-2AD6-46D3-8122-DCF98B808C2F Q34604523-CC7FD493-6452-4877-AC6E-C1882E0C3D1A Q35007847-7F67325B-33D2-4D32-AD4F-B0C372C90B78 Q35187257-97C9977F-C4A7-4B6C-84F6-3C32B51D0559 Q35239944-12BFA123-2BAB-4B3F-80A1-EB0395C8D163 Q36067866-6C9AA729-B4E2-4E45-AB31-4D49920B0601 Q36111849-FC706B91-6575-4353-87D7-2AA0937A21EE Q36170342-D604E06C-8D64-46AE-AC7A-2F6213014666 Q36472907-CACFD854-7562-4178-ABEF-E169ED57FBB8 Q36482236-759A6B15-4424-4630-8F5B-CA76F6C2EC89 Q36715654-24DB6C7D-A0E7-4B2D-B42A-17B412BD7AE2 Q36861531-7987E488-50C7-4E87-9A10-03106A7CFB81 Q37020064-67964FD0-F701-4FC6-96FF-2DBE6DD7DF41 Q37194081-C95964FF-B41E-4277-A532-21FF723E4B35 Q37372319-AC1A7936-9A02-4BEF-AD32-4CFEE2FEC973 Q37409993-331E44B8-434C-4E62-AC2D-4EAE8AB543E9 Q37426965-978323C6-18B4-4E4A-88A8-D2F5B7B5679F Q37479890-B8F36455-6434-43DC-AADE-B7DBD21BCFCD Q37729080-03471674-E05E-490B-879F-5F710BC83CC4 Q37948144-7241E06F-898E-4E60-8442-770421A6F8C8 Q38057868-FA52132B-9BF1-42FA-BD0C-C6B48EF722FE Q38081017-32E1C402-FEF9-4016-915A-71D1EADFC9DE Q38139296-1C3014AF-F035-4636-802F-5F08FBA19748 Q38170033-FDD9F67A-7AD8-485B-BF7A-B866F372875F Q38210965-75EF526E-1A09-44A2-8209-4051C66559B1 Q38353261-44AB5A73-3B26-43B4-AF1B-7F0BF6FA29CF Q38378499-6BE98C52-0C9A-4AA0-A419-55428B243D65 Q38437926-59CA09EA-7370-4EC8-B56E-1F64B05695C8 Q38595322-C9DC0540-AC78-40F0-8E8B-69520507534D

P2860

Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia

http://www.wikidata.org/entity/Q37020101

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 July 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Therapeutic benefits by human ...... hMSCs after cerebral ischemia

@en

Therapeutic benefits by human mesenchymal stem cells

@nl

type

label

Therapeutic benefits by human ...... hMSCs after cerebral ischemia

@en

Therapeutic benefits by human mesenchymal stem cells

@nl

prefLabel

Therapeutic benefits by human ...... hMSCs after cerebral ischemia

@en

Therapeutic benefits by human mesenchymal stem cells

@nl

P1433

Q37020101-DA86CC42-1EC0-4668-95D2-D4049982BAC5

P1476

Q37020101-7BD9F81B-C3D7-48C2-8712-E1211F223243

P2093

Q37020101-5BF5BFC3-8808-4261-B65F-7498DD9A0641

Q37020101-66805D74-B3D9-4D35-8BBA-8D3B08DBD153

Q37020101-73B213AD-A417-478F-8AA9-D8BF1C55EAE6

Q37020101-B76BE1F6-62E1-4448-90B7-285E59A655B3

Q37020101-D2346F62-C86E-4328-AAC8-E98B294B7998

P2860

Q37020101-04484A71-B059-448B-99D8-67FE84D03A9A

Q37020101-05084746-77BF-47E0-A9C8-AE627077E6DC

Q37020101-0F39CA17-9688-40E8-9D80-2A9FE0B4E0C6

Q37020101-15480251-AE95-4B55-9CEB-2112BB1EF7A6

Q37020101-202AD346-E9DD-409B-BD73-A4054F80EB30

Q37020101-241F4825-4210-43E4-825A-8ADD7F4C4C5A

Q37020101-264F9F1C-7E2C-4DF4-93D9-DF6B8E561C62

Q37020101-26DFA523-6975-41FA-A9A4-411E6CFF9B36

Q37020101-29F92CF6-4AD6-4237-AAEF-2DF72E33F612

Q37020101-2B3EE8C5-8E1F-43EF-B4E9-A6C2F9207FF6

P304

Q37020101-51C608DA-247E-49C7-8ADF-72D6DDFB1816

P31

Q37020101-0F75C789-6A07-42F7-959F-EE47DC498697

P356

Q37020101-2082C501-F4A8-48FA-AD96-386EDB60BBD8

P433

Q37020101-B14E5C4D-0D4F-44CD-8159-4E60026485BA

P478

Q37020101-A5682DC0-F574-417D-BB3E-C2B81B691E29

P50

Q37020101-A8A9DB11-BC93-4592-8C73-F7D07D872109

P577

Q37020101-B67B7FC7-0EEC-459D-8A11-414BAE2CA6C0

P5875

Q37020101-FFBF87DF-38E5-4BA3-BB09-9A50D2E91DD0

P698

Q37020101-509D074B-0B48-41F1-B8B6-6D076D367DFF

P921

Q37020101-3956E004-07BD-4A66-B1C6-3A00C8B35425

P932

Q37020101-45B75CC4-5E01-47D6-A9FF-AC5AAA5F3C78

P356

SJ.JCBFM.9600527

P1433

Journal of Cerebral Blood Flow & Metabolism

P1476

Therapeutic benefits by human ...... hMSCs after cerebral ischemia

@en

P2093

Hirofumi Hamada

http://www.w3.org/2001/XMLSchema#string

Jeffery D Kocsis

http://www.w3.org/2001/XMLSchema#string

Kiyohiro Houkin

http://www.w3.org/2001/XMLSchema#string

Kuniaki Harada

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Onda

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning

Angiopoietin-1 induces sprouting angiogenesis in vitro

Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia

Reversible middle cerebral artery occlusion without craniectomy in rats

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1

Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo

Vascular-specific growth factors and blood vessel formation

Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat

Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats.

P304

329-340

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.JCBFM.9600527

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6200266

http://www.w3.org/2001/XMLSchema#string

P698

17637706

http://www.w3.org/2001/XMLSchema#string

P921

cerebral infarction

P932

2605394

http://www.w3.org/2001/XMLSchema#string